alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2
**CERTIFICATION**
I, Phyllis A. Knight, certify that:
1. I have reviewed this report on Form 10-Q of ChampionEnterprises, Inc.; 2. Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respectto the period covered by this report; 3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in allmaterial respects the financial condition, results of operations andcash flows of the registrant as of, and for, the periods presentedin this report; 4. The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have;
a) Designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to be designedunder our supervision, to ensure that material informationrelating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report isbeing prepared; b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered bythis report based on such evaluation; and c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred duringthe registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financialreporting; and
5. The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performingthe equivalent functions):
a) All significant deficiencies and material weaknesses inthe design or operation of internal control over financialreporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and reportfinancial information; and b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in theregistrant’s internal control over financial reporting.   Date:August 4, 2004 /s/ PHYLLIS A. KNIGHT   Phyllis A. Knight Executive Vice President & Chief Financial Officer
Exhibit 15.2





To the
Board of Directors and Partners of


Icahn
Enterprises L.P.





We are
aware of the inclusion in Icahn Enterprises L.P.’s Form 10-Q for the quarter
ended June 30, 2009 and the incorporation by reference in the Registration
Statements (Forms S-3 Nos. 333-126069 and 333-143930 and Form S-4 No.
333-143929) of Icahn Enterprises L.P. of our report dated July 30, 2009 relating
to the unaudited consolidated interim financial statements of Federal-Mogul
Corporation that are included in Federal-Mogul Corporation’s Form 10-Q for the
quarter ended June 30, 2009.





/s/ Ernst & Young
LLP





Detroit,
Michigan


August 5,
2009
ODP Information Bulletin

No. 49, March 7, 2002

TO: All State Administrative Agency Heads

All State Administrative Agency Points of Contact

FROM: C.H. “Butch” Straub II

Director

SUBJECT: Applying for FY 2000 and 2001 Funding

State Administrative Agencies (SAA) are encouraged to apply for Fiscal Year 2000/2001

domestic preparedness funding as soon as possible following notification by the Office for

Domestic Preparedness (ODP) that their state’s Three-Year Domestic Preparedness Strategic

Plan has been approved. A complete Application Kit providing guidance and detailing the

application requirements is provided to each SAA along with the approval letter for their state’s

Strategy. States may not apply for Fiscal Year 2002 funds unless their application for Fiscal Year

2000/2001 funds has been approved by ODP.

As you know, it is critically important to ensure that States and local jurisdictions are as prepared

as possible to respond to an incident of terrorism involving Weapons of Mass Destruction

(WMD). We must therefore do everything in our power to make available the specialized

equipment necessary for a successful response to such an incident.
§ 120.13 Training. ( a ) Only an individual who has met the requirements of paragraph (b) of this section shall be responsible for the following functions: ( 1 ) Developing the hazard analysis, including delineating control measures, as required by § 120.7.
( 2 ) Developing a Hazard Analysis and Critical Control Point (HACCP) plan that is appropriate for a specific processor, in order to meet the requirements of § 120.8;
( 3 ) Verifying and modifying the HACCP plan in accordance with the corrective action procedures specified in § 120.10(b)(5) and the validation activities specified in §§ 120.11(b) and (c); and 120.7;
( 4 ) Performing the record review required by § 120.11(a)(1)(iv).
( b ) The individual performing the functions listed in paragraph (a) of this section shall have successfully completed training in the application of HACCP principles to juice processing at least equivalent to that received under standardized curriculum recognized as adequate by the Food and Drug Administration, or shall be otherwise qualified through job experience to perform these functions. Job experience may qualify an individual to perform these functions if such experience has provided knowledge at least equivalent to that provided through the standardized curriculum. The trained individual need not be an employee of the processor.
Exhibit
31.1



CERTIFICATION



I,
D. Kyle Cerminara, certify that:



|1. | I
    have reviewed this Amendment No. 1 on Form 10-K/A to the annual report on Form 10-K for the year ended December 31, 2018 of
    Ballantyne Strong, Inc.; and                                                                                                                                                    
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                                                                                                       
|2. | Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report.



| | By: | /s/
    D. KYLE CERMINARA                                                                                      
| | --- | ---------------------------------------------------------------------------------------------------------------
| |     | D.
                                         Kyle Cerminara
        Chairman
        and Chief Executive Officer



March
29, 2019
**Exhibit 32**

** **

**CERTIFICATION**

 

The certifications set forth below are herebysubmitted to the Securities and Exchange Commission pursuant to, and solely forthe purpose of complying with, Section 1350 of Chapter 63 of Title 18 of theUnited States Code in connection with the filing on the date hereof with theSecurities and Exchange Commission of the Quarterly Report on Form 10-Q/A of theCompany for the quarter ended September 30, 2003.

 

Each of the undersigned hereby certifies in his capacity as an officerof Citizens Bancshares Corporation and subsidiaries (the “Company”) that theQuarterly Report of the Company on Form 10-Q/A for the period ended September30, 2003 fully complies with the requirements of Section 13(a) of theSecurities Exchange Act of 1934 and that the information contained in suchreport fairly presents, in all material respects, the financial condition ofthe Company at the end of such period and the results of operations of theCompany for such period.

 

**SIGNATURES**

 

In accordance with the requirements of the Exchange Act, the registrantcaused this report to be signed on its behalf by the undersigned, thereuntoduly authorized.

 

**CITIZENS BANCSHARES CORPORATION**

 

 
| Date: January 14, 2004 | By:    | /s/ James E. Young                    |   |
|------------------------|--------|---------------------------------------|--------|
|                   |   | James E. Young                        |
|                   |   | President and Chief Executive Officer |
|                   |   |
| Date: January 14, 2004 | By:    | /s/ Willard C. Lewis                  |   |
|                   |   | Willard C. Lewis                      |
|                   |   | Senior Executive Vice President and   |
|                   |   | Chief Operating Officer               |
|                   |   |
| Date: January 14, 2004 | By:    | /s/ Samuel J. Cox                     |   |
|                   |   | Samuel J. Cox                         |
|                   |   | Senior Vice President and             |
|                   |   | Chief Financial Officer               |

 

1

----
38656.

#### WYATT v. SINGLEY.

Decided February 21, 1961.

*183
      *R. E. Llorens,*for plaintiff in error.

*Sheats, Parker & Webb, Paul Webb, Jr.,*contra.

Felton, Chief Judge.

“There being no market overt in Georgia, but the doctrine of caveat emptor being of force, a purchaser of personal property from one who is not the true owner acquires no title against the true owner by reason of the bona fides of his purchase, when he purchases from, one who is an utter stranger to the title and who can convey no title, except where there may be some statute otherwise, or where the true *184owner, upon some principle of estoppel, would be prevented from asserting his title.” *Singer Sewing Machine Co. v. Wardlaw,*29 Ga. App. 626 (1) (116 S. E. 207); *Guthrie v. Hendley,*56 Ga. App. 438 (193 S. E. 80). It cannot be said that the plaintiff was estopped simply because he voluntarily delivered possession of the automobile to one making fraudulent representation for the purpose of gaining possession of property. “Mere negligence of an owner in putting personal property in the possession of another so that he is given the opportunity to dispose of it is not sufficient to estop the owner.” *Padgett v. Collins,*89 Ga. App. 769, 779 (81 S. E. 2d 309) and cit. “While possession of personal property is presumptive evidence of ownership, the presumption is not conclusive, and any person dealing with the possessor as the owner will not obtain title to the property as against the true owner, unless the latter has done something to mislead or deceive such purchaser.” *Arnold v. Conner,*100 Ga. App. 503 (2) (111 S. E. 2d 638) and cit. Under the facts of the case it does not appear that the plaintiff’s wife was acting as agent for her husband or that she had any authority to represent him in any way with reference to the car.

In accordance with the foregoing principles of law, the court did not err in overruling the defendant’s motion for a new trial.

*Judgment affirmed.*

*Nichols and Bell, JJ., concur.*
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
                              THIS SCHEDULE CONTAINS SUMMARY FINANCIAL 
                              INFORMATION EXTRACTED FROM THE COMPANY'S FINANCIAL
                              STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
                              REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED
                              AS A PART OF THIS FORM 20-F
</LEGEND>
<MULTIPLIER>                                     1,000
<CURRENCY>                                           $
       
<S>                             <C>
<PERIOD-TYPE>                                     Year
<FISCAL-YEAR-END>                          Dec-31-1995
<PERIOD-START>                             Jan-01-1995
<PERIOD-END>                               Dec-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                           4,365
<SECURITIES>                                       490
<RECEIVABLES>                                    8,791
<ALLOWANCES>                                       132
<INVENTORY>                                        723
<CURRENT-ASSETS>                                14,576
<PP&E>                                             611
<DEPRECIATION>                                     179
<TOTAL-ASSETS>                                  16,907
<CURRENT-LIABILITIES>                            3,979
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,593
<OTHER-SE>                                      10,221
<TOTAL-LIABILITY-AND-EQUITY>                    16,907
<SALES>                                         13,824
<TOTAL-REVENUES>                                13,824
<CGS>                                            9,374
<TOTAL-COSTS>                                    2,828
<OTHER-EXPENSES>                                 (122)
<LOSS-PROVISION>                                   132
<INTEREST-EXPENSE>                                 205
<INCOME-PRETAX>                                  1,407
<INCOME-TAX>                                       221
<INCOME-CONTINUING>                              1,186
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  1,125
<CHANGES>                                            0
<NET-INCOME>                                        61
<EPS-PRIMARY>                                     0.01
<EPS-DILUTED>                                     0.01
        

</TABLE>
###### Editorial Note on Part 314

#### Editorial Note:

Nomenclature changes to part 314 appear at 69 FR 13717, Mar. 24, 2004; 81 FR 69639, Oct. 6, 2016.

#### § 314.2 Purpose.

The purpose of this part is to establish an efficient and thorough drug review process in order to: (a) Facilitate the approval of drugs shown to be safe and effective; and (b) ensure the disapproval of drugs not shown to be safe and effective. These regulations are also intended to establish an effective system for FDA's surveillance of marketed drugs. These regulations shall be construed in light of these objectives.
§ 520.2612 Trimethoprim and sulfadiazine suspension. ( a ) *Specifications.* Each milliliter (mL) of suspension contains: ( 1 ) 10 milligrams (mg) trimethoprim and 50 mg sulfadiazine; or
( 2 ) 400 mg combined active ingredients (67 mg trimethoprim and 333 mg sulfadiazine).
( b ) *Sponsors.* See sponsor numbers in § 510.600 of this chapter: ( 1 ) No. 000061 for use of product described in paragraph (a)(1) for use as in paragraph (c)(1) of this section.
( 2 ) No. 051072 for use of product described in paragraph (a)(2) for use as in paragraph (c)(2) of this section.
( c ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Administer 1 mL (10 mg trimethoprim and 50 mg sulfadiazine) per 5 pounds (lb) of body weight once daily, or one-half the recommended daily dose every 12 hours, for up to 14 consecutive days.
( ii ) *Indications for use.* The drug is used in dogs where systemic antibacterial action against sensitive organisms is required, either alone or as an adjunct to surgery or debridement with associated infection. The drug is indicated where control of bacterial infection is required during the treatment of acute urinary tract infections, acute bacterial complications of distemper, acute respiratory tract infections, acute alimentary tract infections, wound infections, and abscesses.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Horses* — ( i ) *Amount.* Administer orally at a dosage of 24 mg combined active ingredients per kilogram body weight (10.9 mg/lb) twice daily for 10 days. Administered by volume at 2.7 mL per 45.4 kilograms of body weight (2.7 mL/100 lb).
( ii ) *Indications for use.* For the treatment of lower respiratory tract infections in horses caused by susceptible strains of *Streptococcus equi* subsp. *zooepidemicus.*
( iii ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[78 FR 63872, Oct. 25, 2013, as amended at 85 FR 4208, Jan. 24, 2020]
[Federal Register Volume 75, Number 38 (Friday, February 26, 2010)]
[Notices]
[Pages 8978-8979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3931]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; ``Diversity Partnership''.
    Date: March 15, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Dennis E. Leszczynski, PhD, Scientific Review 
Officer, Division of Scientific Review, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, NIH, 6100 
Executive Blvd., Rm. 5B01, Bethesda, MD 20892, (301) 435-6884, 
<a href="/cdn-cgi/l/email-protection#224e47515841585b46624f434b4e0c4c4b4a0c454d54"><span class="__cf_email__" data-cfemail="543831272e372e2d301439353d387a3a3d3c7a333b22">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the closing of the Federal Government the week of 
February 7, 2010. The Federal Government was closed due to inclement 
weather conditions.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)


[[Page 8979]]


    Dated: February 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3931 Filed 2-25-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
SUBSIDIARIES OF THE REGISTRANT


                                                                    State or
                                                                      Other
                                                                  Jurisdiction
                                                                      of
                                                      Percentage  Incorporation
                                                          of          of
          Parent                  Subsidiary          Ownership   Subsidiary
-------------------------   ----------------          ----------  -------------
Beal Financial Corporation  Beal Banc Holding            100%     Delaware
                             Company
Beal Financial Corporation  Beal Delaware Corp.          100%     Delaware
Beal Financial Corporation  380 Investors, Inc.          100%     Nevada
Beal Banc Holding Company   Beal Bank, SSB               100%     Texas
Beal Bank, SSB              Beal Mortgage, Inc.          100%     Texas
Beal Bank, SSB              Loan Acceptance Corp.        100%     Texas
Beal Bank, SSB              Property Acceptance          100%     Texas
                            Corp.
Beal Bank, SSB              BRE, Inc.                    100%     Texas
BRE-1, Inc.                 BRE-N, Inc.                  100%     Texas
Beal Bank, SSB              Beal Properties, Inc.        100%     Texas
Beal Bank, SSB              BRE - 3, Inc.                100%     Texas
BRE-1, Inc.                 Beal Affordable              100%     Texas
                            Housing, Inc.
Beal Bank, SSB              BRE-2, Inc.                  100%     Texas
Beal Affordable Housing,    Hebron Trail, Ltd.(1)        99%      Texas
Inc.
Beal Affordable Housing,    Lewisville Manor,            99%      Texas
Inc.                        Ltd.(1)
Beal Affordable Housing,    Valley River Trail,          99%      Texas
Inc.                        Ltd.(1)
Beal Properties, Inc.       Houston Central Green,       50%      Texas
                            LP
Beal Bank, SSB              Beal Nevada Corp.            100%     Nevada
Beal Bank, SSB              BRE-1, Inc.                  100%     Texas
Beal Bank, SSB              Beal/H.S., Inc.              100%     Nevada
Beal/H.S., Inc.             Beal Development,            100%     Texas
                            Ltd.(2)
BRE-2, Inc.                 OC One, Inc.                 100%     Texas
BRE-2, Inc.                 OC Two, Inc.                 100%     Texas
Beal Nevada Corp.           Loan Participant             100%     Texas
                            Partners, Ltd.(3)


(1)   Beal  Affordable  Housing,  Inc.  is a  98%  limited  partner  and  Beal
      Mortgage, Inc. is a 1% general partner in these  entities.
(2)   Beal/H.S., Inc. is a 99% limited partner and Beal Properties,  Inc. is a
      1% general partner.
(3)   Beal Nevada  Corp.  is a 99% limited  partner  and  Property  Acceptance
      Corp. is a 1% general partner.
### Gila RiverIndian Community Departmentof Environmental Qualily Air Program P.O. Box 97 

# - Sacaton, Az. 

## - 85247 

### Phone: (520) 

### 562-2234 Fax:(520) 562-2245 

## EMTR.1NSMlSSlON TO: 

# &d-f;cf 

# 5 

# %vice Aan: $~vv~h 

## %~wfld( Fax: 

# 5coa--*35
Front: 

# 5- ~ivi 

# s Date: 

# 5 

# -27 -05

J 

### Pages (including this page): 

# a, cc: 

### COMMENTS:

### GILA 

### RIVER INDIAN 

## COMMUNlTY DEPARTMENT OF ENVIRONMENTAL QUALITY AIR 

### PROGRAM MEMO DATE: May 27,2005 TO: Ms. Sarah Burnell 

### FROM: Janet Travis, Environmental Project 

### RE. Elderly Concerns Meeting The 

### GRIC Department ofEnvironmental Quality is re uestingplacement on the agenda 

## $ for the upcomingElderly Concerns meeting on June 8 ,2005. The air program would like to present information on proposed ordinances 

### that will regulate sources of air pollutionwithin the Community. We are particularly interested in comments on open 

### burning. Please call me at 520-562-2234 ext. 286 if you have any questions

# 1 TRANSMISSION VERIFICATION REPORT 

# I I TIME : 05/27/2005 14: 51 NAME : DEPT DEQ FAX : 5205622245 TEL : 5205622234



### Gila

### River jndian Community DepartmentofEmiromental Quality Air 

### Program P.O. 

### Box 97 

# - Sacaton, 

### Az. 

# - 85247 

### Phone: (520) 562-2234 

### Fax:(520) 562-2245

-.- .- 

## FAX TR4NSMISSSION

From: 

# gw ~mvj 

# s Date: CJ 

# -77-05 Re: 

# e( &I &cx4Wfl5

# ~5

. 

# Y Pages 

### (incluoYng 

## this page): 

# 2
CC.'